Evidence map›Paper›PMID 40872755›Full record

ArticleViruses2025

Respiratory Virus Prevalence Across Pre-, During-, and Post-SARS-CoV-2 Pandemic Periods.

Michele Manno, Grazia Pavia, Simona Gigliotti, Marta Pantanella, Giorgio Settimo Barreca, Cinzia Peronace, Luigia Gallo, Francesca Trimboli, Elena Colosimo, Angelo Giuseppe Lamberti and 3 more

Abstract read
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Michele MannoUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.
Grazia PaviaUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.ORCID 0000-0002-7685-3419
Simona GigliottiUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.
Marta PantanellaUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.
Giorgio Settimo BarrecaUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.ORCID 0000-0002-2120-8084
Cinzia PeronaceUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.
Luigia GalloUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.
Francesca TrimboliUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.
Elena ColosimoUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.
Angelo Giuseppe LambertiUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.ORCID 0000-0002-5934-8322
Nadia MarascioUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.ORCID 0000-0003-0880-8955
Giovanni MateraUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.
Angela QuirinoUnit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University, A.O.U. "R. Dulbecco", 88100 Catanzaro, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic significantly impacted the circulation, seasonality, and disease burden of viral respiratory infections. This study aimed to evaluate the impact of SARS-CoV-2 on the frequency of viral respiratory infections at a teaching hospital in Southern Italy by comparing data from before, during, and after the COVID-19 pandemic and by investigating how the emergence of SARS-CoV-2 affected the circulation and seasonality of other respiratory viruses. This retrospective and prospective study was performed on de-identified nasopharyngeal specimens classified as pre-COVID-19 (before 15 March 2020), during-COVID-19 (from 16 March 2020 to 5 May 2023), and post-COVID-19 (from 6 May 2023 to 31 December 2024). Overall, 790 out of 3930 (20%) patient samples tested positive for at least one respiratory virus. The mean age of patients was 60 ± 19 years, with significant positivity rates observed in the 65-98 age group (

Indexed as

COVID-19Respiratory Tract InfectionsAdolescentAdultAgedAged, 80 and overChildFemaleHumansInfluenza, HumanItalyMaleMiddle AgedNasopharynxPandemicsPrevalenceCOVID-19 pandemicprevalence of viral respiratory infectionsSARS-CoV-2

Identifiers

PMID40872755
PMCPMC12390457

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.